Education
About Us
Working with TipRanks
Follow Us
Aspen Pharmacare Holdings Limited (APNHF)
OTHER OTC:APNHF
Total Valuation
Aspen Pharmacare Holdings has a market cap or net worth of $3.28B. The enterprise value is $4.66B.
Market Cap$3.28B
Enterprise Value$4.66B
Share Statistics
Aspen Pharmacare Holdings has 446,252,320 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding446,252,320
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aspen Pharmacare Holdings’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 1.17%.
Return on Equity (ROE)-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)1.17%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee4.89M
Profits Per Employee162.06K
Employee Count8,867
Asset Turnover0.32
Inventory Turnover1.35
Valuation Ratios
The current PE Ratio of Aspen Pharmacare Holdings is ―. Aspen Pharmacare Holdings’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.67
Price to FCF0.00
Price to Operating Cash Flow9.69
PEG Ratio―
Income Statement
In the last 12 months, Aspen Pharmacare Holdings had revenue of 43.36B and earned -1.08B in profits. Earnings per share was -2.44.
Revenue43.36B
Gross Profit19.13B
Operating Income1.44B
Pretax Income-123.00M
Net Income-1.08B
EBITDA2.16B
Earnings Per Share (EPS)-2.44
Cash Flow
In the last 12 months, operating cash flow was 5.16B and capital expenditures -2.58B, giving a free cash flow of 2.58B billion.
Operating Cash Flow5.16B
Free Cash Flow2.58B
Free Cash Flow per Share5.79
Dividends & Yields
Aspen Pharmacare Holdings pays an annual dividend of $0.122, resulting in a dividend yield of 1.52%
Dividend Per Share$0.122
Dividend Yield1.52%
Payout Ratio-97.40%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.02
52-Week Price Change-38.44%
50-Day Moving Average6.30
200-Day Moving Average7.51
Relative Strength Index (RSI)99.51
Average Volume (3m)3.00
Important Dates
Aspen Pharmacare Holdings upcoming earnings date is Mar 3, 2026, TBA (Confirmed).
Last Earnings DateSep 3, 2025
Next Earnings DateMar 3, 2026
Ex-Dividend Date―
Financial Position
Aspen Pharmacare Holdings as a current ratio of 2.21, with Debt / Equity ratio of 42.55%
Current Ratio2.21
Quick Ratio1.18
Debt to Market Cap0.63
Net Debt to EBITDA13.75
Interest Coverage Ratio0.87
Taxes
In the past 12 months, Aspen Pharmacare Holdings has paid 960.00M in taxes.
Income Tax960.00M
Effective Tax Rate-7.80
Enterprise Valuation
Aspen Pharmacare Holdings EV to EBITDA ratio is 40.08, with an EV/FCF ratio of 832.75.
EV to Sales2.00
EV to EBITDA40.08
EV to Free Cash Flow832.75
EV to Operating Cash Flow16.79
Balance Sheet
Aspen Pharmacare Holdings has $6.41B in cash and marketable securities with $36.46B in debt, giving a net cash position of -$29.71B billion.
Cash & Marketable Securities$6.41B
Total Debt$36.46B
Net Cash-$29.71B
Net Cash Per Share-$66.58
Tangible Book Value Per Share$28.11
Margins
Gross margin is 44.11%, with operating margin of 3.31%, and net profit margin of -2.50%.
Gross Margin44.11%
Operating Margin3.31%
Pretax Margin-0.28%
Net Profit Margin-2.50%
EBITDA Margin4.98%
EBIT Margin3.52%
Analyst Forecast
The average price target for Aspen Pharmacare Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―